00:00
The second major question that we ask is "Is this patient a candidate for tPA or endovascular
therapy?" If the patient is presented within the appropriate window of time and time is
brain and we've diagnosed this condition a stroke, we want to know whether we can
intervene with tPA intravenously or endovascular therapy through an intervention or
surgical procedure. When we think about this, what's so important is determining the time
that the patient was last normal, when the onset of the symptoms were. When we're talking
with patients and looking at a clinical vignette, many times we first think about well when
did the symptoms begin. But for stroke, that's not good enough. We've got to define the
last known normal. Last known normal as you see here is the time prior to hospital arrival at
which the patient was last known and seen to be without the signs and symptoms of the
current stroke or when the patient was at his/her baseline of health. So if the patient woke
up with stroke symptoms, then the timeline of onset at the time of onset is not when the
patient woke up. It's last night at the time when someone last saw the patient. That's the
last known normal. And for stroke patients, we don't know when the stroke occurred
between when they were last seen normal and when the symptoms were first recognized.
01:22
If we intervene too late in the stroke when that vasogenic edema or ionic edema or necrosis
has occurred, we can increase the risk of hemorrhagic transformation. So we're really
looking to define those patients who are presenting early within the first few hours from
when they were last known normal. So how do we think about the types of acute
interventions that we can administer and the time of presentation for the patient? Well here,
we're going to divide up the time from last known normal. Patients who have presented
within 0 to 4-1/2 hours of last being normal with any stroke type who do not have evidence
of a hemorrhage on a CT are candidates for intervention. And we would consider IV tPA, that's
intravenous administration of tissue plasminogen activator, a clot-busting medicine; or
intra-arterial thrombectomy, a mechanical procedure to pull out that blood clot. And that's
for patients who are presenting early after they were last known to be normal with an
ischemic stroke. For patients who present in that 4.5 to 6-hour range particularly those who
have large NIH stroke scores, and we'll talk about the NIH stroke scale, but here an NIH
stroke scale of greater than 6 are sufficient size of stroke who don't have evidence of
hemorrhage on a non-contrast head CT and who may have areas of abnormality on perfusion.
02:50
Those are areas where we can see that penumbra tissue. There is an infarcted core but it
looks to be a larger area of at risk on perfusion imaging. In those patients, we would also
consider intervention and we may consider IV tPA or may also consider thrombectomy,
but given the features in clinical situation for the patient. And then for patients presenting
late after they were last known to be normal in that 6- or 24-hour range, we would consider
intervention for those with large stroke scale scores who have no evidence of hemorrhage
on the CT with or without perfusion abnormalities and those patients may be considered
for intra-arterial thrombectomy. At that point in time using intravenous tissue plasminogen
activator, IV tPA, increases the risk of hemorrhagic transformation. These general rules are
being changed all the time with later studies and new data, but in general we're looking to
intervene as soon as possible after the patient was last normal. We typically think about
IV tPA in those early presentations and sometimes we'll add thrombectomy to it. And we
want to do the treatment that will bust up that clot and open the artery.